Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Autologous Transplant Followed by Consolidation and Maintenance for Participants ≥ 65 Years of Age Diagnosed With Multiple Myeloma or a Related Plasma Cell Malignancy

NCT01849783 is registered in ClinicalTrials.gov with Margarida Magalhaes-Silverman as lead sponsor.

NCT NCT01849783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01849783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Autologous Transplant Followed by Consolidation and Maintenance for Participants ≥ 65 Years of Age Diagnosed With Multiple Myeloma or a Related Plasma Cell Malignancy
Lead sponsor
Margarida Magalhaes-Silverman
Phase
Phase 2
Overall status
Completed
Start date
April 4, 2013
Completion date
September 30, 2020
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extramedullary plasmacytoma, isolated plasmacytoma of bone, light chain deposition disease, primary systemic amyloidosis, stage i multiple myeloma, stage ii multiple myeloma, stage iii multiple myeloma